Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation
Authors:
- Roberto CarnevaleRoberto Carnevale
- Daniele PastoriDaniele Pastori
- Mariangela PeruzziMPMariangela Peruzzi
- Isotta ChimentiIsotta Chimenti
- Giuseppe Biondi-ZoccaiGiuseppe Biondi-Zoccai
- Antonino G. M. MarulloAMAntonino G. M. Marullo
- Cristina NocellaCristina Nocella
- Francesco VioliFVFrancesco Violi
- Pasquale PignatelliPPPasquale Pignatelli
- Camilla CalvieriCCCamilla Calvieri
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-6
Abstract
Background. Adiponectin (APN) possesses anti-inflammatory and antiatherogenic effects. Atrial fibrillation (AF) is burdened by enhanced systemic inflammation and platelet activation, as documented by increased blood levels of soluble CD40L (sCD40L). The interplay between APN and platelet activation in AF is still undefined.Materials and Methods. Circulating levels of APN and sCD40L were measured in 257 anticoagulated nonvalvular AF patients. Exclusion criteria were as follows: prosthetic heart valves, cardiac revascularization in the previous year, severe cognitive impairment, chronic infectious or autoimmune diseases, and active cancer.Results. Mean age was 72.9 (±8.7) years and 41.6% were female. Serum APN and plasmatic sCD40L were inversely correlated (−0.626,). A progressive increase of sCD40L across tertiles of CHA2DS2-VASc score was observed (rS 0.473,), whilst APN was inversely correlated (rS −0.463, ). A multivariable linear regression analysis showed that CHA2DS2-VASc score (−0.227,) and sCD40L (−0.524,) correlated to APN.Conclusions. AF patients at high risk of stroke disclose low and high levels of APN and sCD40L, respectively, suggesting a role for APN if it favors platelet activation in vivo in this clinical setting. Enhancing APN levels may be a future goal to reduce the risk of vascular outcomes in AF patients.
Keywords
Funding Information
- University of Rome (C26A11J528)
This publication has 42 references indexed in Scilit:
- 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)Journal Of Hypertension, 2013
- Serum total adiponectin level and the risk of cardiovascular disease in general population: A meta-analysis of 17 prospective studiesAtherosclerosis, 2013
- Inflammation in Atrial FibrillationJACC, 2012
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012European Journal of Heart Failure, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Hypoadiponectinemia in Patients With Paroxysmal Atrial FibrillationKorean Circulation Journal, 2012
- Adipokines as novel biomarkers and regulators of the metabolic syndromeAnnals of the New York Academy of Sciences, 2010
- Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patientsAtherosclerosis, 2010
- Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndromeAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial FibrillationStroke, 2007